Figure 4From: Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinibMagnetic resonance imaging (MRI) tumor assessment of Patient 2. Sagittal contrast enhanced (ce) TSE T1 weighted (w) MRI images at baseline showed a lesion located behind the rotula (panel A). After 2 months of imatinib a decrease in tumor size was detected (panel B).Back to article page